MacroGenics PE Ratio 2012-2024 | MGNX
Current and historical p/e ratio for MacroGenics (MGNX) from 2012 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MacroGenics PE ratio as of May 01, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| MacroGenics PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-01 | 1.68 | 0.00 | |
| 2024-12-31 | 3.25 | $-1.08 | 0.00 |
| 2024-09-30 | 3.29 | $-1.58 | 0.00 |
| 2024-06-30 | 4.25 | $-2.20 | 0.00 |
| 2024-03-31 | 14.72 | $-0.39 | 0.00 |
| 2023-12-31 | 9.62 | $-0.16 | 0.00 |
| 2023-09-30 | 4.66 | $0.80 | 5.83 |
| 2023-06-30 | 5.35 | $0.12 | 44.58 |
| 2023-03-31 | 7.17 | $-1.47 | 0.00 |
| 2022-12-31 | 6.71 | $-1.94 | 0.00 |
| 2022-09-30 | 3.46 | $-3.10 | 0.00 |
| 2022-06-30 | 2.95 | $-3.56 | 0.00 |
| 2022-03-31 | 8.81 | $-3.55 | 0.00 |
| 2021-12-31 | 16.05 | $-3.37 | 0.00 |
| 2021-09-30 | 20.94 | $-2.40 | 0.00 |
| 2021-06-30 | 26.86 | $-2.20 | 0.00 |
| 2021-03-31 | 31.85 | $-2.48 | 0.00 |
| 2020-12-31 | 22.86 | $-2.49 | 0.00 |
| 2020-09-30 | 25.19 | $-3.13 | 0.00 |
| 2020-06-30 | 27.92 | $-3.38 | 0.00 |
| 2020-03-31 | 5.82 | $-3.09 | 0.00 |
| 2019-12-31 | 10.88 | $-3.17 | 0.00 |
| 2019-09-30 | 12.76 | $-3.61 | 0.00 |
| 2019-06-30 | 16.97 | $-3.51 | 0.00 |
| 2019-03-31 | 17.98 | $-3.89 | 0.00 |
| 2018-12-31 | 12.70 | $-4.24 | 0.00 |
| 2018-09-30 | 21.44 | $-0.38 | 0.00 |
| 2018-06-30 | 20.65 | $-0.85 | 0.00 |
| 2018-03-31 | 25.16 | $-0.96 | 0.00 |
| 2017-12-31 | 19.00 | $-0.70 | 0.00 |
| 2017-09-30 | 18.48 | $-4.50 | 0.00 |
| 2017-06-30 | 17.51 | $-4.19 | 0.00 |
| 2017-03-31 | 18.60 | $-1.93 | 0.00 |
| 2016-12-31 | 20.44 | $-1.73 | 0.00 |
| 2016-09-30 | 29.91 | $-1.62 | 0.00 |
| 2016-06-30 | 26.99 | $-1.11 | 0.00 |
| 2016-03-31 | 18.75 | $-2.94 | 0.00 |
| 2015-12-31 | 30.97 | $-0.64 | 0.00 |
| 2015-09-30 | 21.42 | $-0.44 | 0.00 |
| 2015-06-30 | 37.97 | $-0.12 | 0.00 |
| 2015-03-31 | 31.37 | $0.15 | 209.13 |
| 2014-12-31 | 35.07 | $-1.39 | 0.00 |
| 2014-09-30 | 20.90 | $-0.84 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.109B | $0.150B |
| MacroGenics Inc. is a biopharmaceutical company. It is focused on discovering and developing innovative monoclonal antibody-based therapeutics. The Company has a diverse portfolio of product candidates focused in three therapeutic areas: oncology, autoimmune disorders and infectious diseases. MacroGenics Inc. is headquartered in Rockville, Maryland. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.763B | 27.35 |
| Boston Scientific (BSX) | United States | $152.152B | 38.10 |
| Stryker (SYK) | United States | $142.721B | 30.67 |
| EssilorLuxottica (ESLOY) | France | $133.556B | 0.00 |
| Medtronic (MDT) | Ireland | $108.708B | 15.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.613B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.796B | 26.03 |
| ResMed (RMD) | United States | $34.691B | 26.06 |
| GE HealthCare Technologies (GEHC) | United States | $32.200B | 15.29 |
| Agilent Technologies (A) | United States | $30.677B | 20.26 |
| Terumo (TRUMY) | Japan | $28.397B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.827B | 17.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.388B | 12.88 |
| Insulet (PODD) | United States | $17.717B | 75.76 |
| Baxter (BAX) | United States | $15.988B | 11.50 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.272B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $7.609B | 0.00 |
| Demant (WILYY) | Denmark | $7.600B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $7.145B | 17.57 |
| Bio-Rad Laboratories (BIO) | United States | $6.837B | 23.67 |
| Prestige Consumer Healthcare (PBH) | United States | $4.024B | 19.20 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.362B | 28.64 |
| Haemonetics (HAE) | United States | $3.166B | 14.90 |
| Envista Holdings (NVST) | United States | $2.725B | 22.03 |
| GN Store Nord (GNNDY) | Denmark | $2.260B | 18.72 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 46.77 |
| QuidelOrtho (QDEL) | United States | $1.875B | 15.70 |
| AtriCure (ATRC) | United States | $1.480B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.401B | 22.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.235B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.148B | 11.05 |
| BioLife Solutions (BLFS) | United States | $1.145B | 0.00 |
| Neogen (NEOG) | United States | $1.096B | 14.03 |
| InMode (INMD) | Israel | $0.981B | 8.98 |
| Phibro Animal Health (PAHC) | United States | $0.754B | 11.56 |
| Evolus (EOLS) | United States | $0.735B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.713B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.580B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Owens & Minor (OMI) | United States | $0.545B | 4.64 |
| Valneva SE (VALN) | France | $0.531B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.514B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.479B | 0.00 |
| Omeros (OMER) | United States | $0.427B | 0.00 |
| Surmodics (SRDX) | United States | $0.400B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.357B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.343B | 14.86 |
| Verano Holdings (VRNOF) | United States | $0.323B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.284B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.279B | 25.25 |
| Aurora Cannabis (ACB) | Canada | $0.261B | 46.40 |
| Canopy Growth (CGC) | Canada | $0.254B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.252B | 15.10 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.231B | 0.00 |
| Quanterix (QTRX) | United States | $0.223B | 0.00 |
| High Tide (HITI) | Canada | $0.195B | 0.00 |
| Biote (BTMD) | United States | $0.182B | 4.16 |
| Utah Medical Products (UTMD) | United States | $0.170B | 13.69 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Brainsway (BWAY) | Israel | $0.164B | 51.00 |
| Organigram Global (OGI) | Canada | $0.146B | 0.00 |
| Jin Medical (ZJYL) | China | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.46 |
| TerrAscend (TSNDF) | Canada | $0.128B | 0.00 |
| Agape ATP (ATPC) | $0.115B | 0.00 | |
| Exagen (XGN) | United States | $0.112B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.082B | 0.00 |
| Veru (VERU) | United States | $0.079B | 0.00 |
| Fonar (FONR) | United States | $0.078B | 10.91 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| United Health Products (UEEC) | United States | $0.065B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Zynex (ZYXI) | United States | $0.050B | 0.00 |
| ImmuCell (ICCC) | United States | $0.049B | 0.00 |
| Modular Medical (MODD) | United States | $0.044B | 0.00 |
| Apyx Medical (APYX) | United States | $0.039B | 0.00 |
| Safety Shot (SHOT) | United States | $0.039B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.037B | 54.00 |
| United-Guardian (UG) | United States | $0.036B | 11.14 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.011B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |